Table 1 Demographics and immunological variables of the NVP-induced rash and NVP-tolerant groups
From: HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
Variables | NVP-induced rash | NVP-tolerant | P value |
|---|---|---|---|
| Â | (n = 39) | (n = 60) | Â |
Age (median IQR) | 39.0 (34.0-44.0) | 38.0 (35.0-41.75) | *0.71 |
Sex [n(%)] | Â | Â | **0.68 |
   Male | 22 (56.41%) | 31 (51.67%) |  |
   Female | 17 (43.59%) | 29 (48.33%) |  |
Duration of Treatment, year (median IQR) | 1 (0-3) | 1 (0-2.75) | *0.47 |
Pre-NVP-treatment CD4 T-cell count × 106/l | 43.5 | 55 | *0.71 |
(median IQR) | (19.50-135.50) | (28.25-137.50) | Â |
Post-NVP-treatment CD4 T-cell count × 106/l | 243 | 241 | *0.98 |
(median IQR) | (155.00-328.00) | (185.00-312.25) | Â |